Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.88
0.76 (14.84%)
At close: Aug 18, 2025, 3:59 PM
5.98
1.70%
Pre-market: Aug 19, 2025, 05:29 AM EDT
14.84% (1D)
| Bid | 5 |
| Market Cap | 8.78M |
| Revenue (ttm) | 11.59M |
| Net Income (ttm) | -5.08M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -4.78 |
| Forward PE | 3.7 |
| Analyst | n/a |
| Ask | 5.98 |
| Volume | 115,421 |
| Avg. Volume (20D) | 2,373,993 |
| Open | 5.11 |
| Previous Close | 5.12 |
| Day's Range | 5.00 - 5.89 |
| 52-Week Range | 1.94 - 12.32 |
| Beta | -0.04 |
About EVOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVOK
Website n/a
Earnings Surprise
Evoke Pharma has released their quartely earnings
on Aug 14, 2025:
Next Earnings Release
Evoke Pharma Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+162.78%
Evoke Pharma shares are trading higher after the c...
Unlock content with
Pro Subscription
8 months ago
+24.77%
Evoke Pharma shares are trading higher after the company highlighted GIMOTI as a solution for Gastroparesis treatment after the Domperidone supply comes to an end.
